BONENCT04615260
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 6 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 21 words
- Trial completed
- Final enrollment: 29 participants (planned 40)
- Minor Trial status: Recruiting to Active, Not Recruiting
- Primary completion date changed from estimate of Dec 2024 to Dec 31, 2024
- Study completion date: Apr 2025 to Apr 30, 2025
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 2021 to Jul 19, 2021
- Site details revised
- Notable Primary completion date: Dec 2023 to Dec 2024
- Start date: Dec 2020 to Sep 2021
- Study completion date: Apr 2024 to Apr 2025
- Notable Primary endpoints revised (2)
- Secondary endpoints revised (2)
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Radiographic Fusion
Timeframe: 12 months
Oswestry Disability Index (ODI) 0% lowest, no disability to 100% disabled, bedridden
Timeframe: 12 months
Secondary (2)
Visual Analog Scale (VAS) 0-no pain to 10-worst possible pain
SF-36 (Short Form 36)
Arms and interventions
Single arm subject is own controlOther
Posterolateral fusion is bilateral, patients will receive the Nanobone graft on the right side of their spine and the local bone graft on their left side.
Devices: NanoBone
Sites
1 site in 1 country
- UMass Memorial Health CareWorcester, Massachusetts, United States